Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01128439 · ClinicalTrials.gov registry record
Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 1
- Enrollment target
NCT01128439: Completed study, sponsored by Pfizer.
NCT01128439 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01128439 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
This study will estimate the incidence of invasive pneumococcal disease in members of the Northern Kaiser Permanente healthcare system during each of the 5 following introduction of Prevnar 13.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-04 |
What the finished NCT01128439 record still lists
NCT01128439 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT01128439 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01128439 about?
NCT01128439 is a clinical study titled "Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease". This study will estimate the incidence of invasive pneumococcal disease in members of the Northern Kaiser Permanente healthcare system during each of the 5 following introduction of Prevnar 13.
What is the current status of trial NCT01128439?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2010-07. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01128439?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT01128439?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia